Stopped: Device needed repairs and delay this would cause would have affected data integrity if study were continued due to treatment delay.
Patients between 4-21 years of age with at least one wart or molluscum lesion are eligible to participate in this study. The duration of the study is a minimum of 4 weeks with the maximum duration of monthly treatments for one year, depending on lesion clearance. The number of lesions will be chosen by the dermatologist. Patients who opt to participate will receive non-thermal, or cold, atmospheric plasma to treat all lesions selected. Safety profile as well as changes in size, pain and appearance will be measured. Photographs and dermatologist impressions will be used to measure treatment response.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Number of lesions with no response
Timeframe: Maximum of 12 months
Number of lesions with partial response
Timeframe: Maximum of 12 months
Number of lesions with complete response
Timeframe: Maximum of 12 months
Number of treatments to complete lesion resolution
Timeframe: Maximum of 12 months